LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
24h
Praegune
Min
4.21
Max
4.27
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +15.02% upside |
By Acuity
58%
42%
311 / 374 Pingereas Healthcare
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
24. okt 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Loe
24. okt 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Loe
24. okt 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Loe
24. okt 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Loe
24. okt 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 4.9 USD 15.02%
Kõrge 5.5 USD
Madal 4 USD
Põhineb 6 Wall Streeti analüütiku instrumendi Adverum Biotechnologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
6 ratings
2
Osta
4
Hoia
0
Müü
Põhineb 6 analüütiku instrumendi Adverum Biotechnologies Inc aktsia reitingul - viimase 3 kuu andmed.
By Acuity
Uudiste sentiment
Tõusu märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Üle keskmise
$